That this House recognises the theme of World Diabetes Day on 14 November 2021 is Access to Diabetes Care; expresses concern that millions of people with diabetes around the world do not have access to diabetes care; that people with diabetes require ongoing care and support to manage their condition and avoid complications; and therefore calls on the Government to increase investment in diabetes care and prevention, and broaden access to medicines to more of the 460 million people living with diabetes and the millions more at risk around the world.

That this House recognises the theme of World Diabetes Day on 14 November 2021 is Access to Diabetes Care; expresses concern that millions of people with diabetes around the world do not have access to diabetes care; that people with diabetes require ongoing care and support to manage their condition...

That this House welcomes the Diabetes UK campaign Measure Up, which aims to reduce the estimated number of 750,000 people in the UK who have diabetes and who are not aware of their condition; further notes the seriousness of diabetes which, if left untreated, can lead to blindness, kidney disease, heart attacks and other life-threatening complications; supports the key messages of the campaign that if you are a white or black male and your waist is 37 inches or more, a woman and your waist is 31.5 inches or more, or a South Asian man and your waist is 35 inches or more, you could need a test for diabetes; observes that keeping people with diabetes healthier will also reduce the long-term impact on limited NHS resources; and calls on the Government to put in place an early identification programme based on the risk factors associated with undiagnosed diabetes.

That this House welcomes the Diabetes UK campaign Measure Up, which aims to reduce the estimated number of 750,000 people in the UK who have diabetes and who are not aware of their condition; further notes the seriousness of diabetes which, if left untreated, can lead to blindness, kidney disease,...

That this House welcomes Diabetes Awareness Week 2007 to be held between 10th and 16th June, at a time when 2.2 million people in the UK suffer from Type 1 and Type 2 diabetes; recognises that the most common complication for diabetes is coronary heart disease and that sufferers are four to six times more likely to die as a result than non-diabetics and are at a higher risk of restenosis (re-narrowing of previous clogged arteries); commends the extensive advances in medical technology specifically designed to treat coronary heart disease; notes that bare metal and drug-eluting stents are successful, cost-effective alternatives to coronary artery bypass grafts as a treatment; further notes that drug-eluting stents significantly lower the likelihood of restenosis in diabetics in comparison to bare metal stents; and urges all health trusts to ensure diabetics are given an informed choice of all treatments available.

That this House welcomes Diabetes Awareness Week 2007 to be held between 10th and 16th June, at a time when 2.2 million people in the UK suffer from Type 1 and Type 2 diabetes; recognises that the most common complication for diabetes is coronary heart disease and that sufferers are...

That this House welcomes Diabetes UK's Diabetes Week (11th to 15th June) campaign to end the postcode lottery for insulin pump therapy; further welcomes the Diabetes Week message that making a small change through providing the technology can make a big difference to the lives of people with diabetes; notes the National Institute for Health and Clinical Excellence (NICE) recommendation that insulin pump therapy should be available as a treatment option for people with type 1 diabetes in cases where multiple dose insulin therapy has failed, and the person is willing and able to use insulin pump therapy effectively; notes with concern that this guidance is not being adhered to locally in a uniform manner; is aware that currently only two per cent. of people with type 1 diabetes use pumps in the UK, compared to 10 to 20 per cent. in other European member states and around 15 to 20 per cent. in the United States; believes that the use of pumps can have cost benefits to the local NHS through a reduction in primary care contracts, reduction in hospital admissions and hospital outpatient contacts; and calls on the Government to oversee the implementation of NICE guidance by primary care organisations to end the postcode lottery.

That this House welcomes Diabetes UK's Diabetes Week (11th to 15th June) campaign to end the postcode lottery for insulin pump therapy; further welcomes the Diabetes Week message that making a small change through providing the technology can make a big difference to the lives of people with diabetes; notes...

That this House welcomes the launch of the Diabetes and the Fire Service: Survey Report, which investigates recruitment and retention practices with regard to people with diabetes in the Fire Service; notes that since the extension to the Disability Discrimination Act in October 2004 people with diabetes are protected from discrimination in the emergency services; notes that well-controlled diabetes is not a bar to working in hazardous occupations such as the fire service; further notes that individual medical assessment is the best method of ascertaining fitness to work; welcomes the main findings of the report that there is widespread recognition of the need to treat all cases individually; notes with regret that there are still variations in recruitment practice across fire and rescue services; and calls on the Government to promote good practice in order to apply it consistently across the UK.

That this House welcomes the launch of the Diabetes and the Fire Service: Survey Report, which investigates recruitment and retention practices with regard to people with diabetes in the Fire Service; notes that since the extension to the Disability Discrimination Act in October 2004 people with diabetes are protected from...

That this House notes with grave concern the increasing problem of diabetes in the UK and internationally; further notes that in many parts of the developing world, because of lack of available treatment and drugs, diabetes can mean certain death; congratulates Diabetes UK on its support for the campaign for a UN resolution on diabetes which would urge member states to improve care and treatment, to adopt robust policies to prevent type 2 diabetes and to promote research into the condition; and calls on the Government to actively support the proposed resolution.

That this House notes with grave concern the increasing problem of diabetes in the UK and internationally; further notes that in many parts of the developing world, because of lack of available treatment and drugs, diabetes can mean certain death; congratulates Diabetes UK on its support for the campaign for...

That this House welcomes the Diabetes UK campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per cent. of these people; further notes the seriousness of diabetes, which if left untreated can lead to blindness, kidney disease, heart attacks and other life-threatening complications; supports the key messages of the campaign that if you are a white or black male and your waist is 37 inches or more, a woman and your waist is 31.5 inches or more, or a South Asian man and your waist is 35 inches or more, you could need a test for diabetes; observes that keeping people with the condition healthier will also reduce the long-term impact on limited NHS resources; expresses its concern over Department of Health figures which show that only 72 per cent. of the diabetic population has been diagnosed across the UK; further notes that some primary care trusts have only diagnosed around half of their diabetic population; and calls on the Government to encourage primary care trusts to spell out their plans for early identification of people with diabetes in their local area.

That this House welcomes the Diabetes UK campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per...

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition of Diabetes UK, the Association of the British Pharmaceutical Society and Ask About Medicines to facilitate understanding of medicines used to treat diabetes; believes that everyone with the condition has a right to expect a personalised information prescription expressed in an appropriate format as part of their care planning process; further believes that such a personalised prescription should help to ensure that access to clear and consistent information that is accurate, up-to-date and trustworthy will enable people with diabetes to understand their condition and treatment options regardless of their age, ethnicity, disability or postcode; further believes that people should be encouraged to seek information on medicines and other treatments by discussing their condition with and asking questions of a range of healthcare professionals and by accessing other forms of support and information tailored for each person in their particular situation; and therefore calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with these standards.

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition...

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected to grow to 350 million in less than 20 years if action is not taken; further notes that diabetes is one of the major causes of premature death worldwide, as every 10 seconds a person dies from diabetes-related causes and death rates are predicted to rise by 25 per cent. over the next decade; further notes that World Health Organisation research predicts that the condition could reduce life expectancy globally for the first time in 200 years and that almost six per cent. of the world's adult population now live with diabetes; and encourages Government support for a United Nations Resolution on diabetes, to secure the Resolution on World Diabetes Day on 14th November 2007.

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected...

That this House welcomes the Diabetes UK's campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per cent. of these people; further notes the seriousness of diabetes, which if left untreated can lead to blindness, kidney disease, heart attacks and other life-threatening complications; supports the key messages of the campaign that if you are a white or black male and your waist is 37 inches or more, a woman and your waist is 31.5 inches or more, or a South Asian man and your waist is 35 inches or more, you could need a test for diabetes; observes that keeping people with the condition healthier will also reduce the long-term impact on limited NHS resources; expresses its concern over Department of Health figures which show that only 72 per cent. of the diabetic population have been diagnosed across the UK; further notes that some primary care trusts have only diagnosed around half of their diabetic population; and calls on the Government to encourage primary care trusts to spell out their plans for early identification of people with diabetes in their local area.

That this House welcomes the Diabetes UK's campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per...

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition of Diabetes UK, the Association of the British Pharmaceutical Society and Ask About Medicines to facilitate understanding of medicines used to treat diabetes; believes everyone with the condition has a right to expect a personalised information prescription expressed in an appropriate format as part of their care planning process; further believes that such a personalised prescription should help ensure that access to clear and consistent information that is accurate, up-to-date and trustworthy enabling people with diabetes to understand their condition and treatment options regardless of their age, ethnicity, disability or postcode; further believes that people should be encouraged to seek information on medicines and other treatments by discussing their condition with and asking questions of a range of healthcare professionals and by accessing other forms of support and information tailored for each person in their particular situation; and therefore calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with these standards.

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition...

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected to grow to 350 million in less than 20 years if action is not taken; further notes that diabetes is one of the major causes of premature death worldwide, as every 10 seconds a person dies from diabetes-related causes and death rates are predicted to rise by 25 per cent. over the next decade; further notes that World Health Organisation research predicts that the condition could reduce life expectancy globally for the first time in 200 years and that almost six per cent. of the world's adult population now live with diabetes; and encourages Government support for a United Nations Resolution on diabetes, to secure the Resolution on World Diabetes Day on 14th November 2007.

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected...

That this House disagrees with the National Institute for Health and Clinical Excellence's recent technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay treatment for as long as four years due to a fear of injections, risking the complications of heart disease, blindness and kidney failure, a situation that will only be compounded by attaching the unfortunate stigma of mental illness to those with a phobia of needles; expresses concern at the additional workload that will be placed on already overstretched NHS psychiatric services; and believes that the judgement of expert clinicians should be trusted in managing each individual patient's condition.

That this House disagrees with the National Institute for Health and Clinical Excellence's recent technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay...

That this House welcomes Diabetes Week, taking place between 11th and 17th June; notes with concern that the number of people diagnosed with diabetes in the United Kingdom has already reached 2.1 million and is expected to reach 3 million by 2010, and that diabetes is now in the top five most common non-contagious diseases in the United Kingdom and is one of the main threats to human health in the 21st century; further notes that diabetes deaths are predicted to rise by 25 per cent. over the next decade and that people with diabetes are five times more likely to die from heart failure as those without diabetes; congratulates Diabetes UK for the positive work that the organisation has undertaken to raise awareness of the rising threat of diabetes and associated diseases; and calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with the standards set out in the National Service Framework for Diabetes.

That this House welcomes Diabetes Week, taking place between 11th and 17th June; notes with concern that the number of people diagnosed with diabetes in the United Kingdom has already reached 2.1 million and is expected to reach 3 million by 2010, and that diabetes is now in the top...

That this House recognises that diabetes is a major cause of ill-health in the UK, affecting more than two million people; notes with concern that the prevalence of diabetes is increasing, particularly among high risk groups such as those who are overweight and those of black or Asian origin; acknowledges that diabetes is a condition largely managed by patients themselves; further notes with concern that the recent Government consultation on the arrangements for the provision of dressings and chemical reagents may lead to a potential reduction of ??19 million in the associated complementary services provided by manufacturers of diabetes testing strips, therefore significantly reducing patients' ability to self-manage their diabetes; and calls on the Government to take urgent steps to reassure patients that any cuts resulting from the consultation will not jeopardise the high quality of diabetes care, products and services currently available.

That this House recognises that diabetes is a major cause of ill-health in the UK, affecting more than two million people; notes with concern that the prevalence of diabetes is increasing, particularly among high risk groups such as those who are overweight and those of black or Asian origin; acknowledges...

That this House notes the interim recommendation made by the National Institute for Health and Clinical Excellence (NICE) not to fund the drug Exubera; believes that inhaled insulin would greatly improve the quality of life for the two million diabetics in the UK who are often forced to inject up to five times a day; further notes that this is the first major breakthrough in the treatment of diabetes since the discovery of insulin in the 1920s; urges the Government and NICE to reconsider its decision; encourages all interested parties to make representations to NICE by 10th May to urge them to reconsider their stance; and hopes that NICE will listen to the growing number of people and organisations who want this inhaled insulin to be freely available.

That this House notes the interim recommendation made by the National Institute for Health and Clinical Excellence (NICE) not to fund the drug Exubera; believes that inhaled insulin would greatly improve the quality of life for the two million diabetics in the UK who are often forced to inject up...

That this House expresses its deep concern that the National Institute for Health and Clinical Excellence (NICE) appraisal consultation document (ACD) recommends that new inhaled insulin should not be available to NHS patients with diabetes although diabetes is a major and growing health problem that affects two million people in the UK, and complications arising from poor management of the condition costs the NHS ??5 billion every year; notes that both the Food and Drug Administration and the European Medicines Evaluation Agency granted inhaled insulin a licence based on robust scientific and medical evidence and that it is one of the most significant medical breakthroughs in diabetes treatment since the discovery of insulin in the 1920s; regrets that the UK had the opportunity to be at the forefront of this development in improving diabetic care, and that the NICE ACD means that patients with diabetes in the UK will either have to pay for this new mode of treatment or continue with the daily multiple injections that lie at the heart of so many problems in managing the disease; and calls upon the Government to find ways to ensure that the NHS provides early and free access to inhaled insulin, so that the benefits of this new approach can be realised for patients in the UK.

That this House expresses its deep concern that the National Institute for Health and Clinical Excellence (NICE) appraisal consultation document (ACD) recommends that new inhaled insulin should not be available to NHS patients with diabetes although diabetes is a major and growing health problem that affects two million people in...

That this House notes with concern the study by the University of Leicester which found physical inactivity in increasing numbers of children is putting them at serious risk of developing diabetes; is concerned by the increasing number of children suffering Type-2 diabetes, a condition which was previously thought only to affect those over the age of 40; further notes that at least 36,000 people in the United Kingdom suffer from diabetes, including 1,000 children, and that another 30,000 people may have the condition undiagnosed; and calls on schools and local authorities to encourage children to take part in, and to enjoy, sport and to discourage parents where appropriate from driving their children to school.

That this House notes with concern the study by the University of Leicester which found physical inactivity in increasing numbers of children is putting them at serious risk of developing diabetes; is concerned by the increasing number of children suffering Type-2 diabetes, a condition which was previously thought only to...

That this House notes that approximately 412,000 people in the UK are likely to develop a new pressure ulcer annually, with the total cost of care estimated at between ??1.4 and ??2.1 billion or four per cent. of the NHS expenditure; further notes that diabetes is becoming a major health problem and that the five per cent. of diabetic patients who will develop a foot ulcer each year are 15 times more likely to need an amputation than people without the condition; believes that such ulcers can be prevented, amputation rates reduced and patients' quality of life improved by using new practices and technologies; congratulates the Tissue Viabililty Nurses Association (TVNA) for bringing this issue to this House's attention; and calls on the Government to work with the TVNA, patient groups and other stakeholders to review current policy and practice in this area.

That this House notes that approximately 412,000 people in the UK are likely to develop a new pressure ulcer annually, with the total cost of care estimated at between ??1.4 and ??2.1 billion or four per cent. of the NHS expenditure; further notes that diabetes is becoming a major health...

That this House believes a significant lack of education is allowing healthcare professionals and patients alike to become confused as to the best and most effective use of blood glucose monitoring for diabetes and that because the current primary care trust guidelines discourage the prescription of blood glucose strips for self-monitoring, it may become difficult for those in primary care to meet the National Institute for Clinical Excellence-recommended blood glucose target levels; and calls on Her Majesty's Government to ensure that blood glucose monitoring strips are not restricted for type II diabetes patients who are best placed to self-manage their condition.

That this House believes a significant lack of education is allowing healthcare professionals and patients alike to become confused as to the best and most effective use of blood glucose monitoring for diabetes and that because the current primary care trust guidelines discourage the prescription of blood glucose strips for...